Labviva: Funding, Investors & Team (Sep 2026)
Labviva is an online platform that connects researchers with suppliers of life science products such as reagents, chemicals, and instrumentation. By using scientific context as the main focus, Labviva makes it easy for researchers to connect with suppliers in a user-friendly way while also allowing suppliers to easily manage and provide product information. Labviva's Inventory Management System (IMS) includes features such as real-time inventory tracking, AI-driven purchase automation, and forecasting, which help to improve operational efficiency and compliance.
Labviva has raised $53.0M across 3 funding rounds on record, the most recent a Series B of $25.0M announced in Jan 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Labviva Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Labviva Funding Rounds
Labviva raised $8.0M in an undisclosed round announced in Jun 2021.
1.8 years later, a Series A of $20.0M was announced in Mar 2023.
1.8 years later, a Series B of $25.0M was announced in Jan 2025.
Labviva Founders and Leadership Team
Contact details for the Labviva team: 2 of 2 have an email address on file.
Start 14-day free trial →Labviva Funding Compared to Other Biotechnology Startups
Labviva's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Labviva in Biotechnology and Cambridge
Companies Similar to Labviva
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Labviva Funding FAQs
What does Labviva do?
Labviva is an online platform that connects researchers with suppliers of life science products such as reagents, chemicals, and instrumentation. By using scientific context as the main focus, Labviva makes it easy for researchers to connect with suppliers in a user-friendly way while also allowing suppliers to easily manage and provide product information. Labviva's Inventory Management System (IMS) includes features such as real-time inventory tracking, AI-driven purchase automation, and forecasting, which help to improve operational efficiency and compliance.
How much funding has Labviva raised?
Labviva has raised $53.0M across 3 rounds on record. The most recent is a Series B of $25.0M announced in Jan 2025.
When did Labviva last raise funding?
Labviva's most recent funding round on record is a Series B of $25.0M, announced in Jan 2025.
Who founded Labviva?
FundedIQ lists Nicholas Rioux (Founder) at Labviva.
Who is the CEO of Labviva?
Siamak Baharloo is listed as CEO at Labviva.
Where is Labviva headquartered?
Labviva is based in Cambridge, Massachusetts, United States.
How many employees does Labviva have?
Labviva is in the 101-250 employee band.
How does Labviva's funding compare to other Biotechnology startups?
Labviva's latest round of $25.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Labviva Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Labviva is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.